Pharma & Healthcare
Global Plasma-derived Factor VIII Market Research Report 2025
- Sep 09, 25
- ID: 497196
- Pages: 78
- Figures: 85
- Views: 4
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasma-derived Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma-derived Factor VIII.
The Plasma-derived Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plasma-derived Factor VIII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma-derived Factor VIII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Takeda
Octapharma
CSL
Grifols
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Segment by Type
200IU
250IU
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plasma-derived Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plasma-derived Factor VIII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Plasma-derived Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma-derived Factor VIII.
The Plasma-derived Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plasma-derived Factor VIII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma-derived Factor VIII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Takeda
Octapharma
CSL
Grifols
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Segment by Type
200IU
250IU
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plasma-derived Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plasma-derived Factor VIII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Plasma-derived Factor VIII Market Overview
1.1 Product Definition
1.2 Plasma-derived Factor VIII by Type
1.2.1 Global Plasma-derived Factor VIII Market Value Comparison by Type (2024 VS 2031)
1.2.2 200IU
1.2.3 250IU
1.3 Plasma-derived Factor VIII by Application
1.3.1 Global Plasma-derived Factor VIII Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Plasma-derived Factor VIII Market Size Estimates and Forecasts
1.4.1 Global Plasma-derived Factor VIII Revenue 2020-2031
1.4.2 Global Plasma-derived Factor VIII Sales 2020-2031
1.4.3 Global Plasma-derived Factor VIII Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Plasma-derived Factor VIII Market Competition by Manufacturers
2.1 Global Plasma-derived Factor VIII Sales Market Share by Manufacturers (2020-2025)
2.2 Global Plasma-derived Factor VIII Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Plasma-derived Factor VIII Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Plasma-derived Factor VIII, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Plasma-derived Factor VIII, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plasma-derived Factor VIII, Product Type & Application
2.7 Global Key Manufacturers of Plasma-derived Factor VIII, Date of Enter into This Industry
2.8 Global Plasma-derived Factor VIII Market Competitive Situation and Trends
2.8.1 Global Plasma-derived Factor VIII Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Plasma-derived Factor VIII Players Market Share by Revenue
2.8.3 Global Plasma-derived Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Plasma-derived Factor VIII Market Scenario by Region
3.1 Global Plasma-derived Factor VIII Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Plasma-derived Factor VIII Sales by Region: 2020-2031
3.2.1 Global Plasma-derived Factor VIII Sales by Region: 2020-2025
3.2.2 Global Plasma-derived Factor VIII Sales by Region: 2026-2031
3.3 Global Plasma-derived Factor VIII Revenue by Region: 2020-2031
3.3.1 Global Plasma-derived Factor VIII Revenue by Region: 2020-2025
3.3.2 Global Plasma-derived Factor VIII Revenue by Region: 2026-2031
3.4 North America Plasma-derived Factor VIII Market Facts & Figures by Country
3.4.1 North America Plasma-derived Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Plasma-derived Factor VIII Sales by Country (2020-2031)
3.4.3 North America Plasma-derived Factor VIII Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Plasma-derived Factor VIII Market Facts & Figures by Country
3.5.1 Europe Plasma-derived Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Plasma-derived Factor VIII Sales by Country (2020-2031)
3.5.3 Europe Plasma-derived Factor VIII Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasma-derived Factor VIII Market Facts & Figures by Region
3.6.1 Asia Pacific Plasma-derived Factor VIII Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Plasma-derived Factor VIII Sales by Region (2020-2031)
3.6.3 Asia Pacific Plasma-derived Factor VIII Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Plasma-derived Factor VIII Market Facts & Figures by Country
3.7.1 Latin America Plasma-derived Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Plasma-derived Factor VIII Sales by Country (2020-2031)
3.7.3 Latin America Plasma-derived Factor VIII Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plasma-derived Factor VIII Market Facts & Figures by Country
3.8.1 Middle East and Africa Plasma-derived Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Plasma-derived Factor VIII Sales by Country (2020-2031)
3.8.3 Middle East and Africa Plasma-derived Factor VIII Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Plasma-derived Factor VIII Sales by Type (2020-2031)
4.1.1 Global Plasma-derived Factor VIII Sales by Type (2020-2025)
4.1.2 Global Plasma-derived Factor VIII Sales by Type (2026-2031)
4.1.3 Global Plasma-derived Factor VIII Sales Market Share by Type (2020-2031)
4.2 Global Plasma-derived Factor VIII Revenue by Type (2020-2031)
4.2.1 Global Plasma-derived Factor VIII Revenue by Type (2020-2025)
4.2.2 Global Plasma-derived Factor VIII Revenue by Type (2026-2031)
4.2.3 Global Plasma-derived Factor VIII Revenue Market Share by Type (2020-2031)
4.3 Global Plasma-derived Factor VIII Price by Type (2020-2031)
5 Segment by Application
5.1 Global Plasma-derived Factor VIII Sales by Application (2020-2031)
5.1.1 Global Plasma-derived Factor VIII Sales by Application (2020-2025)
5.1.2 Global Plasma-derived Factor VIII Sales by Application (2026-2031)
5.1.3 Global Plasma-derived Factor VIII Sales Market Share by Application (2020-2031)
5.2 Global Plasma-derived Factor VIII Revenue by Application (2020-2031)
5.2.1 Global Plasma-derived Factor VIII Revenue by Application (2020-2025)
5.2.2 Global Plasma-derived Factor VIII Revenue by Application (2026-2031)
5.2.3 Global Plasma-derived Factor VIII Revenue Market Share by Application (2020-2031)
5.3 Global Plasma-derived Factor VIII Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Plasma-derived Factor VIII Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Octapharma
6.2.1 Octapharma Company Information
6.2.2 Octapharma Description and Business Overview
6.2.3 Octapharma Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Octapharma Plasma-derived Factor VIII Product Portfolio
6.2.5 Octapharma Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Plasma-derived Factor VIII Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Company Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Grifols Plasma-derived Factor VIII Product Portfolio
6.4.5 Grifols Recent Developments/Updates
6.5 Greencross
6.5.1 Greencross Company Information
6.5.2 Greencross Description and Business Overview
6.5.3 Greencross Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Greencross Plasma-derived Factor VIII Product Portfolio
6.5.5 Greencross Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Company Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kedrion Plasma-derived Factor VIII Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 BPL
6.7.1 BPL Company Information
6.7.2 BPL Description and Business Overview
6.7.3 BPL Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BPL Plasma-derived Factor VIII Product Portfolio
6.7.5 BPL Recent Developments/Updates
6.8 Hualan Bio
6.8.1 Hualan Bio Company Information
6.8.2 Hualan Bio Description and Business Overview
6.8.3 Hualan Bio Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hualan Bio Plasma-derived Factor VIII Product Portfolio
6.8.5 Hualan Bio Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Company Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.9.4 RAAS Plasma-derived Factor VIII Product Portfolio
6.9.5 RAAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasma-derived Factor VIII Industry Chain Analysis
7.2 Plasma-derived Factor VIII Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasma-derived Factor VIII Production Mode & Process Analysis
7.4 Plasma-derived Factor VIII Sales and Marketing
7.4.1 Plasma-derived Factor VIII Sales Channels
7.4.2 Plasma-derived Factor VIII Distributors
7.5 Plasma-derived Factor VIII Customer Analysis
8 Plasma-derived Factor VIII Market Dynamics
8.1 Plasma-derived Factor VIII Industry Trends
8.2 Plasma-derived Factor VIII Market Drivers
8.3 Plasma-derived Factor VIII Market Challenges
8.4 Plasma-derived Factor VIII Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Plasma-derived Factor VIII by Type
1.2.1 Global Plasma-derived Factor VIII Market Value Comparison by Type (2024 VS 2031)
1.2.2 200IU
1.2.3 250IU
1.3 Plasma-derived Factor VIII by Application
1.3.1 Global Plasma-derived Factor VIII Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Plasma-derived Factor VIII Market Size Estimates and Forecasts
1.4.1 Global Plasma-derived Factor VIII Revenue 2020-2031
1.4.2 Global Plasma-derived Factor VIII Sales 2020-2031
1.4.3 Global Plasma-derived Factor VIII Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Plasma-derived Factor VIII Market Competition by Manufacturers
2.1 Global Plasma-derived Factor VIII Sales Market Share by Manufacturers (2020-2025)
2.2 Global Plasma-derived Factor VIII Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Plasma-derived Factor VIII Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Plasma-derived Factor VIII, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Plasma-derived Factor VIII, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plasma-derived Factor VIII, Product Type & Application
2.7 Global Key Manufacturers of Plasma-derived Factor VIII, Date of Enter into This Industry
2.8 Global Plasma-derived Factor VIII Market Competitive Situation and Trends
2.8.1 Global Plasma-derived Factor VIII Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Plasma-derived Factor VIII Players Market Share by Revenue
2.8.3 Global Plasma-derived Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Plasma-derived Factor VIII Market Scenario by Region
3.1 Global Plasma-derived Factor VIII Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Plasma-derived Factor VIII Sales by Region: 2020-2031
3.2.1 Global Plasma-derived Factor VIII Sales by Region: 2020-2025
3.2.2 Global Plasma-derived Factor VIII Sales by Region: 2026-2031
3.3 Global Plasma-derived Factor VIII Revenue by Region: 2020-2031
3.3.1 Global Plasma-derived Factor VIII Revenue by Region: 2020-2025
3.3.2 Global Plasma-derived Factor VIII Revenue by Region: 2026-2031
3.4 North America Plasma-derived Factor VIII Market Facts & Figures by Country
3.4.1 North America Plasma-derived Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Plasma-derived Factor VIII Sales by Country (2020-2031)
3.4.3 North America Plasma-derived Factor VIII Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Plasma-derived Factor VIII Market Facts & Figures by Country
3.5.1 Europe Plasma-derived Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Plasma-derived Factor VIII Sales by Country (2020-2031)
3.5.3 Europe Plasma-derived Factor VIII Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasma-derived Factor VIII Market Facts & Figures by Region
3.6.1 Asia Pacific Plasma-derived Factor VIII Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Plasma-derived Factor VIII Sales by Region (2020-2031)
3.6.3 Asia Pacific Plasma-derived Factor VIII Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Plasma-derived Factor VIII Market Facts & Figures by Country
3.7.1 Latin America Plasma-derived Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Plasma-derived Factor VIII Sales by Country (2020-2031)
3.7.3 Latin America Plasma-derived Factor VIII Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plasma-derived Factor VIII Market Facts & Figures by Country
3.8.1 Middle East and Africa Plasma-derived Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Plasma-derived Factor VIII Sales by Country (2020-2031)
3.8.3 Middle East and Africa Plasma-derived Factor VIII Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Plasma-derived Factor VIII Sales by Type (2020-2031)
4.1.1 Global Plasma-derived Factor VIII Sales by Type (2020-2025)
4.1.2 Global Plasma-derived Factor VIII Sales by Type (2026-2031)
4.1.3 Global Plasma-derived Factor VIII Sales Market Share by Type (2020-2031)
4.2 Global Plasma-derived Factor VIII Revenue by Type (2020-2031)
4.2.1 Global Plasma-derived Factor VIII Revenue by Type (2020-2025)
4.2.2 Global Plasma-derived Factor VIII Revenue by Type (2026-2031)
4.2.3 Global Plasma-derived Factor VIII Revenue Market Share by Type (2020-2031)
4.3 Global Plasma-derived Factor VIII Price by Type (2020-2031)
5 Segment by Application
5.1 Global Plasma-derived Factor VIII Sales by Application (2020-2031)
5.1.1 Global Plasma-derived Factor VIII Sales by Application (2020-2025)
5.1.2 Global Plasma-derived Factor VIII Sales by Application (2026-2031)
5.1.3 Global Plasma-derived Factor VIII Sales Market Share by Application (2020-2031)
5.2 Global Plasma-derived Factor VIII Revenue by Application (2020-2031)
5.2.1 Global Plasma-derived Factor VIII Revenue by Application (2020-2025)
5.2.2 Global Plasma-derived Factor VIII Revenue by Application (2026-2031)
5.2.3 Global Plasma-derived Factor VIII Revenue Market Share by Application (2020-2031)
5.3 Global Plasma-derived Factor VIII Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Plasma-derived Factor VIII Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Octapharma
6.2.1 Octapharma Company Information
6.2.2 Octapharma Description and Business Overview
6.2.3 Octapharma Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Octapharma Plasma-derived Factor VIII Product Portfolio
6.2.5 Octapharma Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Plasma-derived Factor VIII Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Company Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Grifols Plasma-derived Factor VIII Product Portfolio
6.4.5 Grifols Recent Developments/Updates
6.5 Greencross
6.5.1 Greencross Company Information
6.5.2 Greencross Description and Business Overview
6.5.3 Greencross Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Greencross Plasma-derived Factor VIII Product Portfolio
6.5.5 Greencross Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Company Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kedrion Plasma-derived Factor VIII Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 BPL
6.7.1 BPL Company Information
6.7.2 BPL Description and Business Overview
6.7.3 BPL Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BPL Plasma-derived Factor VIII Product Portfolio
6.7.5 BPL Recent Developments/Updates
6.8 Hualan Bio
6.8.1 Hualan Bio Company Information
6.8.2 Hualan Bio Description and Business Overview
6.8.3 Hualan Bio Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hualan Bio Plasma-derived Factor VIII Product Portfolio
6.8.5 Hualan Bio Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Company Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.9.4 RAAS Plasma-derived Factor VIII Product Portfolio
6.9.5 RAAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasma-derived Factor VIII Industry Chain Analysis
7.2 Plasma-derived Factor VIII Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasma-derived Factor VIII Production Mode & Process Analysis
7.4 Plasma-derived Factor VIII Sales and Marketing
7.4.1 Plasma-derived Factor VIII Sales Channels
7.4.2 Plasma-derived Factor VIII Distributors
7.5 Plasma-derived Factor VIII Customer Analysis
8 Plasma-derived Factor VIII Market Dynamics
8.1 Plasma-derived Factor VIII Industry Trends
8.2 Plasma-derived Factor VIII Market Drivers
8.3 Plasma-derived Factor VIII Market Challenges
8.4 Plasma-derived Factor VIII Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Plasma-derived Factor VIII Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Plasma-derived Factor VIII Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Plasma-derived Factor VIII Market Competitive Situation by Manufacturers in 2024
Table 4. Global Plasma-derived Factor VIII Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Plasma-derived Factor VIII Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Plasma-derived Factor VIII Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Plasma-derived Factor VIII Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Plasma-derived Factor VIII Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Plasma-derived Factor VIII, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Plasma-derived Factor VIII, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Plasma-derived Factor VIII, Product Type & Application
Table 12. Global Key Manufacturers of Plasma-derived Factor VIII, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Plasma-derived Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Factor VIII as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Plasma-derived Factor VIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Plasma-derived Factor VIII Sales by Region (2020-2025) & (K Units)
Table 18. Global Plasma-derived Factor VIII Sales Market Share by Region (2020-2025)
Table 19. Global Plasma-derived Factor VIII Sales by Region (2026-2031) & (K Units)
Table 20. Global Plasma-derived Factor VIII Sales Market Share by Region (2026-2031)
Table 21. Global Plasma-derived Factor VIII Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Plasma-derived Factor VIII Revenue Market Share by Region (2020-2025)
Table 23. Global Plasma-derived Factor VIII Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Plasma-derived Factor VIII Revenue Market Share by Region (2026-2031)
Table 25. North America Plasma-derived Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Plasma-derived Factor VIII Sales by Country (2020-2025) & (K Units)
Table 27. North America Plasma-derived Factor VIII Sales by Country (2026-2031) & (K Units)
Table 28. North America Plasma-derived Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Plasma-derived Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Plasma-derived Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Plasma-derived Factor VIII Sales by Country (2020-2025) & (K Units)
Table 32. Europe Plasma-derived Factor VIII Sales by Country (2026-2031) & (K Units)
Table 33. Europe Plasma-derived Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Plasma-derived Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Plasma-derived Factor VIII Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Plasma-derived Factor VIII Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Plasma-derived Factor VIII Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Plasma-derived Factor VIII Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Plasma-derived Factor VIII Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Plasma-derived Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Plasma-derived Factor VIII Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Plasma-derived Factor VIII Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Plasma-derived Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Plasma-derived Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Plasma-derived Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Plasma-derived Factor VIII Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Plasma-derived Factor VIII Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Plasma-derived Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Plasma-derived Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Plasma-derived Factor VIII Sales (K Units) by Type (2020-2025)
Table 51. Global Plasma-derived Factor VIII Sales (K Units) by Type (2026-2031)
Table 52. Global Plasma-derived Factor VIII Sales Market Share by Type (2020-2025)
Table 53. Global Plasma-derived Factor VIII Sales Market Share by Type (2026-2031)
Table 54. Global Plasma-derived Factor VIII Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Plasma-derived Factor VIII Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Plasma-derived Factor VIII Revenue Market Share by Type (2020-2025)
Table 57. Global Plasma-derived Factor VIII Revenue Market Share by Type (2026-2031)
Table 58. Global Plasma-derived Factor VIII Price (USD/Unit) by Type (2020-2025)
Table 59. Global Plasma-derived Factor VIII Price (USD/Unit) by Type (2026-2031)
Table 60. Global Plasma-derived Factor VIII Sales (K Units) by Application (2020-2025)
Table 61. Global Plasma-derived Factor VIII Sales (K Units) by Application (2026-2031)
Table 62. Global Plasma-derived Factor VIII Sales Market Share by Application (2020-2025)
Table 63. Global Plasma-derived Factor VIII Sales Market Share by Application (2026-2031)
Table 64. Global Plasma-derived Factor VIII Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Plasma-derived Factor VIII Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Plasma-derived Factor VIII Revenue Market Share by Application (2020-2025)
Table 67. Global Plasma-derived Factor VIII Revenue Market Share by Application (2026-2031)
Table 68. Global Plasma-derived Factor VIII Price (USD/Unit) by Application (2020-2025)
Table 69. Global Plasma-derived Factor VIII Price (USD/Unit) by Application (2026-2031)
Table 70. Takeda Company Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Takeda Plasma-derived Factor VIII Product
Table 74. Takeda Recent Developments/Updates
Table 75. Octapharma Company Information
Table 76. Octapharma Description and Business Overview
Table 77. Octapharma Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Octapharma Plasma-derived Factor VIII Product
Table 79. Octapharma Recent Developments/Updates
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. CSL Plasma-derived Factor VIII Product
Table 84. CSL Recent Developments/Updates
Table 85. Grifols Company Information
Table 86. Grifols Description and Business Overview
Table 87. Grifols Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Grifols Plasma-derived Factor VIII Product
Table 89. Grifols Recent Developments/Updates
Table 90. Greencross Company Information
Table 91. Greencross Description and Business Overview
Table 92. Greencross Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Greencross Plasma-derived Factor VIII Product
Table 94. Greencross Recent Developments/Updates
Table 95. Kedrion Company Information
Table 96. Kedrion Description and Business Overview
Table 97. Kedrion Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Kedrion Plasma-derived Factor VIII Product
Table 99. Kedrion Recent Developments/Updates
Table 100. BPL Company Information
Table 101. BPL Description and Business Overview
Table 102. BPL Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. BPL Plasma-derived Factor VIII Product
Table 104. BPL Recent Developments/Updates
Table 105. Hualan Bio Company Information
Table 106. Hualan Bio Description and Business Overview
Table 107. Hualan Bio Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Hualan Bio Plasma-derived Factor VIII Product
Table 109. Hualan Bio Recent Developments/Updates
Table 110. RAAS Company Information
Table 111. RAAS Description and Business Overview
Table 112. RAAS Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. RAAS Plasma-derived Factor VIII Product
Table 114. RAAS Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Plasma-derived Factor VIII Distributors List
Table 118. Plasma-derived Factor VIII Customers List
Table 119. Plasma-derived Factor VIII Market Trends
Table 120. Plasma-derived Factor VIII Market Drivers
Table 121. Plasma-derived Factor VIII Market Challenges
Table 122. Plasma-derived Factor VIII Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Plasma-derived Factor VIII
Figure 2. Global Plasma-derived Factor VIII Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Plasma-derived Factor VIII Market Share by Type: 2024 & 2031
Figure 4. 200IU Product Picture
Figure 5. 250IU Product Picture
Figure 6. Global Plasma-derived Factor VIII Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Plasma-derived Factor VIII Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Plasma-derived Factor VIII Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Plasma-derived Factor VIII Market Size (2020-2031) & (US$ Million)
Figure 12. Global Plasma-derived Factor VIII Sales (2020-2031) & (K Units)
Figure 13. Global Plasma-derived Factor VIII Average Price (USD/Unit) & (2020-2031)
Figure 14. Plasma-derived Factor VIII Report Years Considered
Figure 15. Plasma-derived Factor VIII Sales Share by Manufacturers in 2024
Figure 16. Global Plasma-derived Factor VIII Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Plasma-derived Factor VIII Players: Market Share by Revenue in Plasma-derived Factor VIII in 2024
Figure 18. Plasma-derived Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Plasma-derived Factor VIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Plasma-derived Factor VIII Sales Market Share by Country (2020-2031)
Figure 21. North America Plasma-derived Factor VIII Revenue Market Share by Country (2020-2031)
Figure 22. United States Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Mexico Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Plasma-derived Factor VIII Sales Market Share by Country (2020-2031)
Figure 26. Europe Plasma-derived Factor VIII Revenue Market Share by Country (2020-2031)
Figure 27. Germany Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. UK Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Plasma-derived Factor VIII Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Plasma-derived Factor VIII Revenue Market Share by Region (2020-2031)
Figure 34. China Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Plasma-derived Factor VIII Sales Market Share by Country (2020-2031)
Figure 44. Latin America Plasma-derived Factor VIII Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Plasma-derived Factor VIII Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Plasma-derived Factor VIII Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Plasma-derived Factor VIII by Type (2020-2031)
Figure 54. Global Revenue Market Share of Plasma-derived Factor VIII by Type (2020-2031)
Figure 55. Global Plasma-derived Factor VIII Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Plasma-derived Factor VIII by Application (2020-2031)
Figure 57. Global Revenue Market Share of Plasma-derived Factor VIII by Application (2020-2031)
Figure 58. Global Plasma-derived Factor VIII Price (USD/Unit) by Application (2020-2031)
Figure 59. Plasma-derived Factor VIII Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Plasma-derived Factor VIII Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Plasma-derived Factor VIII Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Plasma-derived Factor VIII Market Competitive Situation by Manufacturers in 2024
Table 4. Global Plasma-derived Factor VIII Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Plasma-derived Factor VIII Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Plasma-derived Factor VIII Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Plasma-derived Factor VIII Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Plasma-derived Factor VIII Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Plasma-derived Factor VIII, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Plasma-derived Factor VIII, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Plasma-derived Factor VIII, Product Type & Application
Table 12. Global Key Manufacturers of Plasma-derived Factor VIII, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Plasma-derived Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Factor VIII as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Plasma-derived Factor VIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Plasma-derived Factor VIII Sales by Region (2020-2025) & (K Units)
Table 18. Global Plasma-derived Factor VIII Sales Market Share by Region (2020-2025)
Table 19. Global Plasma-derived Factor VIII Sales by Region (2026-2031) & (K Units)
Table 20. Global Plasma-derived Factor VIII Sales Market Share by Region (2026-2031)
Table 21. Global Plasma-derived Factor VIII Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Plasma-derived Factor VIII Revenue Market Share by Region (2020-2025)
Table 23. Global Plasma-derived Factor VIII Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Plasma-derived Factor VIII Revenue Market Share by Region (2026-2031)
Table 25. North America Plasma-derived Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Plasma-derived Factor VIII Sales by Country (2020-2025) & (K Units)
Table 27. North America Plasma-derived Factor VIII Sales by Country (2026-2031) & (K Units)
Table 28. North America Plasma-derived Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Plasma-derived Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Plasma-derived Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Plasma-derived Factor VIII Sales by Country (2020-2025) & (K Units)
Table 32. Europe Plasma-derived Factor VIII Sales by Country (2026-2031) & (K Units)
Table 33. Europe Plasma-derived Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Plasma-derived Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Plasma-derived Factor VIII Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Plasma-derived Factor VIII Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Plasma-derived Factor VIII Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Plasma-derived Factor VIII Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Plasma-derived Factor VIII Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Plasma-derived Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Plasma-derived Factor VIII Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Plasma-derived Factor VIII Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Plasma-derived Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Plasma-derived Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Plasma-derived Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Plasma-derived Factor VIII Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Plasma-derived Factor VIII Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Plasma-derived Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Plasma-derived Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Plasma-derived Factor VIII Sales (K Units) by Type (2020-2025)
Table 51. Global Plasma-derived Factor VIII Sales (K Units) by Type (2026-2031)
Table 52. Global Plasma-derived Factor VIII Sales Market Share by Type (2020-2025)
Table 53. Global Plasma-derived Factor VIII Sales Market Share by Type (2026-2031)
Table 54. Global Plasma-derived Factor VIII Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Plasma-derived Factor VIII Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Plasma-derived Factor VIII Revenue Market Share by Type (2020-2025)
Table 57. Global Plasma-derived Factor VIII Revenue Market Share by Type (2026-2031)
Table 58. Global Plasma-derived Factor VIII Price (USD/Unit) by Type (2020-2025)
Table 59. Global Plasma-derived Factor VIII Price (USD/Unit) by Type (2026-2031)
Table 60. Global Plasma-derived Factor VIII Sales (K Units) by Application (2020-2025)
Table 61. Global Plasma-derived Factor VIII Sales (K Units) by Application (2026-2031)
Table 62. Global Plasma-derived Factor VIII Sales Market Share by Application (2020-2025)
Table 63. Global Plasma-derived Factor VIII Sales Market Share by Application (2026-2031)
Table 64. Global Plasma-derived Factor VIII Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Plasma-derived Factor VIII Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Plasma-derived Factor VIII Revenue Market Share by Application (2020-2025)
Table 67. Global Plasma-derived Factor VIII Revenue Market Share by Application (2026-2031)
Table 68. Global Plasma-derived Factor VIII Price (USD/Unit) by Application (2020-2025)
Table 69. Global Plasma-derived Factor VIII Price (USD/Unit) by Application (2026-2031)
Table 70. Takeda Company Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Takeda Plasma-derived Factor VIII Product
Table 74. Takeda Recent Developments/Updates
Table 75. Octapharma Company Information
Table 76. Octapharma Description and Business Overview
Table 77. Octapharma Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Octapharma Plasma-derived Factor VIII Product
Table 79. Octapharma Recent Developments/Updates
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. CSL Plasma-derived Factor VIII Product
Table 84. CSL Recent Developments/Updates
Table 85. Grifols Company Information
Table 86. Grifols Description and Business Overview
Table 87. Grifols Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Grifols Plasma-derived Factor VIII Product
Table 89. Grifols Recent Developments/Updates
Table 90. Greencross Company Information
Table 91. Greencross Description and Business Overview
Table 92. Greencross Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Greencross Plasma-derived Factor VIII Product
Table 94. Greencross Recent Developments/Updates
Table 95. Kedrion Company Information
Table 96. Kedrion Description and Business Overview
Table 97. Kedrion Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Kedrion Plasma-derived Factor VIII Product
Table 99. Kedrion Recent Developments/Updates
Table 100. BPL Company Information
Table 101. BPL Description and Business Overview
Table 102. BPL Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. BPL Plasma-derived Factor VIII Product
Table 104. BPL Recent Developments/Updates
Table 105. Hualan Bio Company Information
Table 106. Hualan Bio Description and Business Overview
Table 107. Hualan Bio Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Hualan Bio Plasma-derived Factor VIII Product
Table 109. Hualan Bio Recent Developments/Updates
Table 110. RAAS Company Information
Table 111. RAAS Description and Business Overview
Table 112. RAAS Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. RAAS Plasma-derived Factor VIII Product
Table 114. RAAS Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Plasma-derived Factor VIII Distributors List
Table 118. Plasma-derived Factor VIII Customers List
Table 119. Plasma-derived Factor VIII Market Trends
Table 120. Plasma-derived Factor VIII Market Drivers
Table 121. Plasma-derived Factor VIII Market Challenges
Table 122. Plasma-derived Factor VIII Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Plasma-derived Factor VIII
Figure 2. Global Plasma-derived Factor VIII Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Plasma-derived Factor VIII Market Share by Type: 2024 & 2031
Figure 4. 200IU Product Picture
Figure 5. 250IU Product Picture
Figure 6. Global Plasma-derived Factor VIII Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Plasma-derived Factor VIII Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Plasma-derived Factor VIII Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Plasma-derived Factor VIII Market Size (2020-2031) & (US$ Million)
Figure 12. Global Plasma-derived Factor VIII Sales (2020-2031) & (K Units)
Figure 13. Global Plasma-derived Factor VIII Average Price (USD/Unit) & (2020-2031)
Figure 14. Plasma-derived Factor VIII Report Years Considered
Figure 15. Plasma-derived Factor VIII Sales Share by Manufacturers in 2024
Figure 16. Global Plasma-derived Factor VIII Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Plasma-derived Factor VIII Players: Market Share by Revenue in Plasma-derived Factor VIII in 2024
Figure 18. Plasma-derived Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Plasma-derived Factor VIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Plasma-derived Factor VIII Sales Market Share by Country (2020-2031)
Figure 21. North America Plasma-derived Factor VIII Revenue Market Share by Country (2020-2031)
Figure 22. United States Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Mexico Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Plasma-derived Factor VIII Sales Market Share by Country (2020-2031)
Figure 26. Europe Plasma-derived Factor VIII Revenue Market Share by Country (2020-2031)
Figure 27. Germany Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. UK Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Plasma-derived Factor VIII Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Plasma-derived Factor VIII Revenue Market Share by Region (2020-2031)
Figure 34. China Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Plasma-derived Factor VIII Sales Market Share by Country (2020-2031)
Figure 44. Latin America Plasma-derived Factor VIII Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Plasma-derived Factor VIII Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Plasma-derived Factor VIII Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Plasma-derived Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Plasma-derived Factor VIII by Type (2020-2031)
Figure 54. Global Revenue Market Share of Plasma-derived Factor VIII by Type (2020-2031)
Figure 55. Global Plasma-derived Factor VIII Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Plasma-derived Factor VIII by Application (2020-2031)
Figure 57. Global Revenue Market Share of Plasma-derived Factor VIII by Application (2020-2031)
Figure 58. Global Plasma-derived Factor VIII Price (USD/Unit) by Application (2020-2031)
Figure 59. Plasma-derived Factor VIII Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232